Family-owned drug factories in India erode US generic pricesPost published:August 31, 2017Post category:Industry NewsExpansion by Indian pharma firms is boosting competition in the US, where mergers and pricing wars among drugmakers had already been driving down cost of generics Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostRBI mandates 50% provisioning for NCLT cases Next PostHow Nandan Nilekani returned to Infosys You Might Also Like Siemens releases Siship BlueDrive Eco green propulsion system September 4, 2018 Making an IoT System? Here are 5 Protocols to Consider January 5, 2018 Turck announces TX700 programmable series of HMI/PLCs July 26, 2019